GIANETTA NORWOOD: Open Payments
NPI 1619250289 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,160 in 88 payments from 42 companies in 2025. Trend: 2023 $2,218 · 2024 $3,108 · 2025 $2,160
Food & beverage: $2,160
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $272 |
| Daiichi Sankyo Inc. | 4 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $120 |
| AstraZeneca Pharmaceuticals LP | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| Janssen Biotech, Inc. | 3 | $92 |
| Celgene Corporation | 3 | $77 |
| ABBVIE INC. | 3 | $69 |
| Eisai Inc. | 3 | $68 |
| Karyopharm Therapeutics Inc. | 2 | $66 |
Products named: KEYTRUDA, Enhertu, NINLARO, KISQALI, TALVEY, REBLOZYL, Lenvima, XPOVIO.
Industry payments across IL — which companies pay providers there.
